Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

1p/19q chromosome deletions in metastatic oligodendroglioma.

Merrell R, Nabors LB, Perry A, Palmer CA.

J Neurooncol. 2006 Nov;80(2):203-7.

PMID:
16710746
2.

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.

Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A.

J Neuropathol Exp Neurol. 2004 Apr;63(4):314-22.

3.

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW.

Front Biosci. 2003 Jan 1;8:a1-9.

PMID:
12456321
4.

Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K.

J Neurooncol. 2009 Jan;91(1):33-8. doi: 10.1007/s11060-008-9690-6.

PMID:
18781279
7.

Molecular genetic study of a metastatic oligodendroglioma.

Giordana MT, Ghimenti C, Leonardo E, Balteri I, Iudicello M, Duò D.

J Neurooncol. 2004 Feb;66(3):265-71.

PMID:
15015656
8.

Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?

Gadji M, Fortin D, Tsanaclis AM, Drouin R.

Cancer Genet Cytogenet. 2009 Oct;194(1):12-22. doi: 10.1016/j.cancergencyto.2009.05.004.

PMID:
19737649
9.

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K.

Cancer. 2005 Oct 1;104(7):1468-77.

10.

Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.

Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.

Clin Neuropathol. 2006 Jan-Feb;25(1):18-24.

PMID:
16465770
11.

Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.

Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.

Mod Pathol. 2003 Jul;16(7):708-15.

12.

Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.

Molinari C, Iorio P, Medri L, Ballardini M, Guiducci G, Cremonini AM, Cerasoli S, Riccioni L, Faedi M, Mariani GA, Zoli W, Silvestrini R, Calistri D.

Int J Mol Med. 2010 Jan;25(1):145-51.

PMID:
19956913
13.

Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.

Sonabend AM, Lesniak MS.

Expert Rev Neurother. 2005 Nov;5(6 Suppl):S25-32. Review.

PMID:
16274268
14.

Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.

Singh VY, Chacko G, Chacko AG, Rajshekhar V.

Neurol India. 2014 Jan-Feb;62(1):32-6. doi: 10.4103/0028-3886.128275. Erratum in: Neurol India. 2014 Mar-Apr;62(2):191.

15.

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A; German Glioma Network..

Clin Cancer Res. 2007 Dec 1;13(23):6933-7.

16.

Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.

Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.

Genes Chromosomes Cancer. 2005 Jan;42(1):68-77.

PMID:
15472895
17.

Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.

Lavon I, Zrihan D, Zelikovitch B, Fellig Y, Fuchs D, Soffer D, Siegal T.

Clin Cancer Res. 2007 Mar 1;13(5):1429-37.

18.

Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?

Campbell BA, Horsman DE, Maguire J, Young S, Curman D, Ma R, Thiessen B.

J Neurooncol. 2008 Aug;89(1):37-45. doi: 10.1007/s11060-008-9597-2.

PMID:
18458822
19.

Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.

Li G, Zhang Z, Zhang J, Jin T, Liang H, Gong L, Cui G, Yang H, He S, Zhang Y, Gao G.

Diagn Pathol. 2014 Jan 21;9:17. doi: 10.1186/1746-1596-9-17. Review.

20.

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.

Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.

Cancer. 2005 Feb 15;103(4):802-9.

Items per page

Supplemental Content

Support Center